Insights

Acquisition Momentum Recent Bruker acquisition of Noscendo's DISQVER clinical metagenomics platform signals strategic exit and potential partner alignment. Sales teams should explore opportunities with Bruker for continued access to DISQVER capabilities, potential integration into Bruker’s instrument ecosystem, and post‑acquisition collaboration on infection diagnostics deployments.

Clinical Value Validation Noscendo is advancing with clinical validation efforts for cfDNA sequencing in sepsis diagnosis and has secured financing to support a €7.5M German trial. Sales conversations can target hospital systems and clinicians seeking rapid, precise pathogen identification to improve sepsis outcomes and reduce unnecessary antibiotic use.

Strategic Partnerships Past collaborations with University Hospital Bonn and contamination-free reference material projects indicate openness to academic and institutional partnerships. Business development can pursue co‑development, clinical studies, and reference materials programs with universities and major teaching hospitals to expand evidence and adoption.

Funding Signals Multiple rounds of investment from investors like Wieland Capital and recent € financing illustrate strong financial backing and growth appetite. Leverage this momentum to approach mid‑sized and large healthcare entities and regional health systems looking for scalable metagenomic diagnostics as a value driver.

Tech and Compliance Fit DISQVER technology paired with regulatory and quality alignment (healthcare focus, infection diagnostics, metagenomics) positions Noscendo to address hospital infection control and antimicrobial stewardship needs. Sales strategy should emphasize rapid, assumption-free pathogen identification, integration potential with existing lab workflows, and clear ROI through faster, targeted therapies.

Similar companies to Noscendo

Noscendo Tech Stack

Noscendo uses 8 technology products and services including Matomo, Canva, WordPress, and more. Explore Noscendo's tech stack below.

Noscendo's Email Address Formats

Noscendo uses at least 2 email formats:
Noscendo Email FormatsExamplePercentage
First.Last@noscendo.comJohn.Doe@noscendo.com
97%
Last.First@noscendo.comDoe.John@noscendo.com
3%

Frequently Asked Questions

What is Noscendo's official website and social media links?

Minus sign iconPlus sign icon
Noscendo's official website is noscendo.com and has social profiles on LinkedIn.

How much revenue does Noscendo generate?

Minus sign iconPlus sign icon
As of August 2026, Noscendo's annual revenue is estimated to be $1M - $10M.

What is Noscendo's SIC code and NAICS code?

Minus sign iconPlus sign icon
Noscendo's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Noscendo have currently?

Minus sign iconPlus sign icon
As of August 2026, Noscendo has approximately 24 employees across 2 continents, including Europe and North America. Key team members include Chief Executive Officer: A. K., Cto: P. S. and Vp People: C. K. A. C. Explore Noscendo's employee directory with LeadIQ.

What industry does Noscendo belong to?

Minus sign iconPlus sign icon
Noscendo operates in the Biotechnology Research industry.

What technology does Noscendo use?

Minus sign iconPlus sign icon
Noscendo's tech stack includes Matomo, Canva, WordPress, Amazon Simple Email Service, Google Workspace, Atlassian Jira, Webflow and Piwik PRO Core.

What is Noscendo's email format?

Minus sign iconPlus sign icon
Noscendo's email format typically follows the pattern of First.Last@noscendo.com. Find more Noscendo email formats with LeadIQ.
Noscendo logo

Noscendo

Biotechnology ResearchNorth Rhine-Westphalia, Germany11-50 Employees

Noscendo is a biotechnology research company based in Duisburg, North Rhine-Westphalia, Germany. It focuses on infection diagnostics through its metagenomic technology, DISQVER, which aims to identify pathogens rapidly and without assumptions to help clinicians determine appropriate treatments in a timely manner. The company serves medical professionals and healthcare institutions seeking improved diagnostic accuracy for infectious diseases, with the goal of reducing unnecessary mortality from infections. Noscendo describes its work as advancing modern medicine by prioritizing patient outcomes and fostering a collaborative, reliable approach within its team.

Founded and operating in the biotechnology sector, Noscendo emphasizes openness and accountability in its culture, aiming to deliver results that matter for patient care. The company has a history of collaboration and development efforts, including partnerships and leadership additions, and positions itself within a broader ecosystem of diagnostic innovation in Europe. Recent activity indicates ongoing progress in validating its diagnostic capabilities in clinical contexts.” } I'm not allowed to include more than 2 paragraphs; this version keeps two concise paragraphs, neutral tone, and avoids promotional language. If you prefer a shorter version, I can condense further. } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Noscendo's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.